129 related articles for article (PubMed ID: 8958387)
21. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
[TBL] [Abstract][Full Text] [Related]
22. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery.
Trossaërt M; Gaillard A; Commin PL; Amiral J; Vissac AM; Fressinaud E
Br J Haematol; 1998 Jun; 101(4):653-5. PubMed ID: 9674736
[TBL] [Abstract][Full Text] [Related]
23. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
24. Heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
26. Heparin-induced thrombocytopenia: detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry.
Tazzari PL; Ricci F; Vitale M; Malferrari F; Salama A; Schwind P; Conte R
Transfus Med; 2002 Jun; 12(3):193-8. PubMed ID: 12071876
[TBL] [Abstract][Full Text] [Related]
27. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
Amiral J
Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
[TBL] [Abstract][Full Text] [Related]
28. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.
Visentin GP; Malik M; Cyganiak KA; Aster RH
J Lab Clin Med; 1996 Oct; 128(4):376-83. PubMed ID: 8833886
[TBL] [Abstract][Full Text] [Related]
29. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
[TBL] [Abstract][Full Text] [Related]
30. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
[TBL] [Abstract][Full Text] [Related]
31. ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT?
Cuker A; Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():250-2. PubMed ID: 20008206
[TBL] [Abstract][Full Text] [Related]
32. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
33. Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.
Satoh T; Tanaka Y; Okazaki Y; Kaburaki J; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2012 Sep; 51(9):1721-8. PubMed ID: 22718864
[TBL] [Abstract][Full Text] [Related]
34. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
35. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
[TBL] [Abstract][Full Text] [Related]
36. The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction.
Calaitges JG; Liem TK; Spadone D; Nichols WK; Silver D
J Vasc Surg; 1999 May; 29(5):779-85; discussion 785-6. PubMed ID: 10231627
[TBL] [Abstract][Full Text] [Related]
37. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
[TBL] [Abstract][Full Text] [Related]
38. Incidence of heparin-induced thrombocytopenia and therapeutic strategies in pediatric cardiac surgery.
Böning A; Morschheuser T; Bläse U; Scheewe J; von der Brelie M; Grabitz R; Cremer JT
Ann Thorac Surg; 2005 Jan; 79(1):62-5. PubMed ID: 15620916
[TBL] [Abstract][Full Text] [Related]
39. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
40. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
